Register entry

Orient Pharma Co., Ltd.

Data as of · How to read this entry

Registered sites
1
Active NDC listings
1
Live patents
0
Countries
1
Base
Taiwan
Authorisation

Registered operations

Analytical testing1Labelling1Finished drug manufacture1Packaging1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Orient Pharma Co., Ltd. QC LABORATORYRegistrant: Orient Pharma Co., Ltd.Rm. A342, A334, A335, A356, A338 and A339, 3F, No. 16, Kehu 1st Rd., Huwei Township, Yunlin County, 632007, Taiwan (TWN)Analytical testing, Labelling, Finished drug manufacture, Packaging3009057557658875409
Catalogue

Marketed products

1
BrandGeneric nameForm / routeNDC
EzetimibeEzetimibetablet, oral76333-170ANDA
Compare

Comparable companies in Taiwan

Enquiry

Common questions

Is Orient Pharma Co., Ltd. FDA approved?
Orient Pharma Co., Ltd. holds 1 FDA-registered establishment in Taiwan. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Orient Pharma Co., Ltd.'s drugs manufactured?
The FDA register lists Yunlin County. Registered operations: analytical testing, labelling, finished drug manufacture, packaging.
What drugs does Orient Pharma Co., Ltd. make?
1 product is listed under Orient Pharma Co., Ltd. in the openFDA NDC Directory, most often as tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.